Remission strategies and mechanism-targeted interventions are key frontiers in diabetes research, aiming to achieve sustained glycemic control and restore metabolic balance. This session highlights approaches to address insulin resistance, beta-cell dysfunction, and immune dysregulation beyond current therapies. Topics include beta-cell preservation and regeneration, immunomodulatory and gene-based approaches, precision pharmacotherapy, therapeutic technologies, and digital innovations. Emphasis is placed on safety, specificity, and durability through biomarker development, imaging tools, and translational research, along with clinical, ethical, and regulatory considerations.
We invite researchers, clinicians, and industry experts to submit one-page abstracts for presentation at the Diabetes Conference and share innovations shaping the future of diabetes care.